178 related articles for article (PubMed ID: 26056442)
1. Effects of PVA coated nanoparticles on human immune cells.
Strehl C; Gaber T; Maurizi L; Hahne M; Rauch R; Hoff P; Häupl T; Hofmann-Amtenbrink M; Poole AR; Hofmann H; Buttgereit F
Int J Nanomedicine; 2015; 10():3429-45. PubMed ID: 26056442
[TBL] [Abstract][Full Text] [Related]
2. Effects of PVA-coated nanoparticles on human T helper cell activity.
Strehl C; Schellmann S; Maurizi L; Hofmann-Amtenbrink M; Häupl T; Hofmann H; Buttgereit F; Gaber T
Toxicol Lett; 2016 Mar; 245():52-8. PubMed ID: 26774940
[TBL] [Abstract][Full Text] [Related]
3. The in-vivo use of superparamagnetic iron oxide nanoparticles to detect inflammation elicits a cytokine response but does not aggravate experimental arthritis.
Vermeij EA; Koenders MI; Bennink MB; Crowe LA; Maurizi L; Vallée JP; Hofmann H; van den Berg WB; van Lent PL; van de Loo FA
PLoS One; 2015; 10(5):e0126687. PubMed ID: 25955417
[TBL] [Abstract][Full Text] [Related]
4. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.
Petri-Fink A; Chastellain M; Juillerat-Jeanneret L; Ferrari A; Hofmann H
Biomaterials; 2005 May; 26(15):2685-94. PubMed ID: 15585272
[TBL] [Abstract][Full Text] [Related]
5. Modification of the surface of superparamagnetic iron oxide nanoparticles to enable their safe application in humans.
Strehl C; Maurizi L; Gaber T; Hoff P; Broschard T; Poole AR; Hofmann H; Buttgereit F
Int J Nanomedicine; 2016; 11():5883-5896. PubMed ID: 27877036
[TBL] [Abstract][Full Text] [Related]
6. Amino-polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles are suitable for monitoring of human mesenchymal stromal cells in vivo.
Schulze F; Dienelt A; Geissler S; Zaslansky P; Schoon J; Henzler K; Guttmann P; Gramoun A; Crowe LA; Maurizi L; Vallée JP; Hofmann H; Duda GN; Ode A
Small; 2014 Nov; 10(21):4340-51. PubMed ID: 24990430
[TBL] [Abstract][Full Text] [Related]
7. Uptake and biocompatibility of functionalized poly(vinylalcohol) coated superparamagnetic maghemite nanoparticles by synoviocytes in vitro.
Schulze K; Koch A; Petri-Fink A; Steitz B; Kamau S; Hottiger M; Hilbe M; Vaughan L; Hofmann M; Hofmann H; von Rechenberg B
J Nanosci Nanotechnol; 2006; 6(9-10):2829-40. PubMed ID: 17048489
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of mannan-coated superparamagnetic iron oxide nanoparticles to antigen-presenting cells for magnetic resonance-based diagnosis of metastatic lymph nodes in vivo.
Vu-Quang H; Yoo MK; Jeong HJ; Lee HJ; Muthiah M; Rhee JH; Lee JH; Cho CS; Jeong YY; Park IK
Acta Biomater; 2011 Nov; 7(11):3935-45. PubMed ID: 21763797
[TBL] [Abstract][Full Text] [Related]
9. Monitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophages.
Gramoun A; Crowe LA; Maurizi L; Wirth W; Tobalem F; Grosdemange K; Coullerez G; Eckstein F; Koenders MI; Van den Berg WB; Hofmann H; Vallée JP
Arthritis Res Ther; 2014 Jun; 16(3):R131. PubMed ID: 24957862
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution, kinetics, and biological fate of SPION microbubbles in the rat.
Barrefelt Å; Saghafian M; Kuiper R; Ye F; Egri G; Klickermann M; Brismar TB; Aspelin P; Muhammed M; Dähne L; Hassan M
Int J Nanomedicine; 2013; 8():3241-54. PubMed ID: 24023513
[TBL] [Abstract][Full Text] [Related]
11. Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging.
Mahmoudi M; Simchi A; Imani M; Milani AS; Stroeve P
J Phys Chem B; 2008 Nov; 112(46):14470-81. PubMed ID: 18729404
[TBL] [Abstract][Full Text] [Related]
12. Poly(vinyl alcohol) physical hydrogel nanoparticles, not polymer solutions, exert inhibition of nitric oxide synthesis in cultured macrophages.
Andreasen SØ; Chong SF; Wohl BM; Goldie KN; Zelikin AN
Biomacromolecules; 2013 May; 14(5):1687-95. PubMed ID: 23560438
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of amino-polyvinyl alcohol-coated superparamagnetic iron oxide nanoparticles in bone marrow: implications for local stromal cells.
Schulze F; Gramoun A; Crowe LA; Dienelt A; Akcan T; Hofmann H; Vallée JP; Duda GN; Ode A
Nanomedicine (Lond); 2015 Jul; 10(14):2139-51. PubMed ID: 26214354
[TBL] [Abstract][Full Text] [Related]
14. Degradation of superparamagnetic iron oxide nanoparticle-induced ferritin by lysosomal cathepsins and related immune response.
Laskar A; Ghosh M; Khattak SI; Li W; Yuan XM
Nanomedicine (Lond); 2012 May; 7(5):705-17. PubMed ID: 22500704
[TBL] [Abstract][Full Text] [Related]
15. Anti-Platelet Effect Induced by Iron Oxide Nanoparticles: Correlation with Conformational Change in Fibrinogen.
Kottana RK; Maurizi L; Schnoor B; Morris K; Webb JA; Massiah MA; Millot N; Papa AL
Small; 2021 Jan; 17(1):e2004945. PubMed ID: 33284518
[TBL] [Abstract][Full Text] [Related]
16. Preparation of an efficient and safe polymeric-magnetic nanoparticle delivery system for sorafenib in hepatocellular carcinoma.
Tom G; Philip S; Isaac R; Praseetha PK; Jiji SG; Asha VV
Life Sci; 2018 Aug; 206():10-21. PubMed ID: 29709652
[TBL] [Abstract][Full Text] [Related]
17. A 'degradable' poly(vinyl alcohol) iron oxide nanoparticle hydrogel.
Bannerman AD; Li X; Wan W
Acta Biomater; 2017 Aug; 58():376-385. PubMed ID: 28499634
[TBL] [Abstract][Full Text] [Related]
18. Iron oxide nanoparticles and induced autophagy in human monocytes.
Wu Q; Jin R; Feng T; Liu L; Yang L; Tao Y; Anderson JM; Ai H; Li H
Int J Nanomedicine; 2017; 12():3993-4005. PubMed ID: 28603414
[TBL] [Abstract][Full Text] [Related]
19. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
[TBL] [Abstract][Full Text] [Related]
20. Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells.
Kunzmann A; Andersson B; Vogt C; Feliu N; Ye F; Gabrielsson S; Toprak MS; Buerki-Thurnherr T; Laurent S; Vahter M; Krug H; Muhammed M; Scheynius A; Fadeel B
Toxicol Appl Pharmacol; 2011 Jun; 253(2):81-93. PubMed ID: 21435349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
